1 | Mirikizumab (D11123) | 1件: Mirikizumab Mirikizumab | 1件: Mirikizumab
Mirikizumab
(D11123) 💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 3件: 37 37, 96, 97 💬
|
2 | Mirikizumab IV (D11123) | 1件: Mirikizumab Mirikizumab | 1件: Mirikizumab
Mirikizumab
(D11123) 💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 97 97 💬
|
3 | Mirikizumab SC (D11123) | 1件: Mirikizumab Mirikizumab | 1件: Mirikizumab
Mirikizumab
(D11123) 💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 97 97 💬
|